Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00835952 · ClinicalTrials.gov registry record · Phase 1
ATX-101 Abdominoplasty
A Phase 1 study of Characteristics of Subcutaneous Fat, sponsored by Kythera Biopharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
- 2
- Study locations
NCT00835952 is a Phase 1 study of Characteristics of Subcutaneous Fat that has completed, run by Kythera Biopharmaceuticals. The registered enrollment target is 14 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT00835952, a Phase 1 study of Characteristics of Subcutaneous Fat, has completed, sponsored by Kythera Biopharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
- 2
- Study locations
Study Summary
Histopathological study of abdominal fat excised from subjects undergoing abdominoplasty
Conditions Studied
Interventions
- DRUG ATX-101
Study Locations (2)
California
- - San Francisco
- - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00835952
The ClinicalTrials.gov registry entry for NCT00835952 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kythera Biopharmaceuticals, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Characteristics of Subcutaneous Fat appearing as the primary indexed condition, and to 1 intervention - of which ATX-101 is the first listed.
NCT00835952 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00835952 about?
NCT00835952 is a clinical study titled "ATX-101 Abdominoplasty". Histopathological study of abdominal fat excised from subjects undergoing abdominoplasty
What is the current status of trial NCT00835952?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2008-11. Estimated completion is 2009-04.
What conditions does trial NCT00835952 study?
This clinical trial studies the following conditions: Characteristics of Subcutaneous Fat.
What interventions are being tested in trial NCT00835952?
The interventions under investigation include: ATX-101 (DRUG).
Who is sponsoring clinical trial NCT00835952?
This trial is sponsored by Kythera Biopharmaceuticals, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00835952 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.